The global wearable injectors market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.6 Billion by 2028, exhibiting a growth rate (CAGR) of 14.8% during 2023-2028. More Info:- https://www.imarcgroup.com/wearable-injectors-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Wearable Injectors
Market Research and
Forecast Report 2023-2028
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Wearable Injectors Market Research Report:
The latest report by IMARC, titled “Wearable Injectors Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028” finds that the global wearable injectors market size
reached US$ 6.6 Billion in 2022.
Wearable injectors (WIs) or patch pumps are drug delivery devices utilized for the single-step
administration of medicines for longer durations. They automatically deliver preset doses to patients at
optimal times. They are temporarily attached to the skin to deliver viscous drugs in large volumes
faster and safely through the subcutaneous tissues in the body.
They comprise a cannula for substance delivery to tissues, a reservoir to store medicine, and a drive
system to provide the appropriate drug volume. In addition, these devices are user-friendly,
disposable, and cause minimal discomfort and pain compared to traditionally used syringes and vials.
As a result, wearable injectors are extensively used for the treatment of diabetes, rheumatoid arthritis,
cancer, and cardiovascular diseases.
Request Free Sample Report: https://www.imarcgroup.com/wearable-injectors-
market/requestsample

4. Report Description
Report Description and Highlights
Global Wearable Injectors Market Trends:
The market is primarily driven by the increasing prevalence of chronic medical illnesses such as neurological,
oncological, and autoimmune disorders. In addition, the rising geriatric population, which is more susceptible to such
ailments, and the escalating demand for minimally invasive (MI) treatment alternatives among the patients represent
other major growth-inducing factors. Moreover, the sudden outbreak of the coronavirus disease (COVID-19)
pandemic prompted the entire healthcare system to switch to home-based therapies to stop the spread of the
sickness. This, coupled with the growing popularity of at-home and self-administrable injectors to effectively manage
disorders with the minutest risks of inaccurate dosage and needle stick injuries, is providing a positive thrust to the
market growth.
Besides this, various product innovations, such as the incorporation of wireless connectivity, passive warning systems,
and Bluetooth technologies with the injectors, are anticipated to propel the market growth. These technologies
promote convenient monitoring of the patient through a smartphone application and offer timely reminders for
dosages. Furthermore, extensive research and development (R&D) activities, along with significant improvements in
the healthcare infrastructure, are creating a positive market outlook. Looking forward, IMARC Group expects the
market value to reach US$ 15.6 Billion by 2028, exhibiting a CAGR of 14.8% during the forecast period (2023-2028).
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Type:
• On-body
• Off-body
Breakup by Technology:
• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Others
Breakup by Application:
• Oncology
• Infectious Diseases
• Cardiovascular Diseases
• Autoimmune Diseases
• Others

6. Report Description
Report Description and Highlights
Breakup by End Use:
• Hospitals and Clinics
• Home Care
• Others
Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany

7. Report Description
Report Description and Highlights
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

8. Competitive Landscape with Key Players:
• Becton Dickinson and Company
• CeQur SA
• Debiotech SA
• Dexcom Inc.
• Enable Injections Inc.
• Gerresheimer AG
• Insulet Corporation
• Tandem Diabetes Care Inc.
• West Pharmaceutical Services Inc.
• Ypsomed AG
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/wearable-injectors-market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us